Importance of chronic fibroproliferative diseases (FDs) including pulmonary fibrosis, chronic
kidney diseases, inflammatory bowel disease, and cardiovascular or liver fibrosis is rapidly …

Both communicable and non-communicable chronic respiratory conditions have accorded
for suffering of millions of people of all ages and stated to be leading cause of death …

Idiopathic pulmonary fibrosis (IPF) is a progressive and chronic inflammatory disease with a
poor prognosis and very few available treatment options. Low-level laser therapy (LLLT) has …

The present study evaluated the effect of epigallocatechin-3-gallate (EGCG), the most
abundant catechin in green tea, on irradiation-induced pulmonary fibrosis and elucidated its …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown
etiology. Immune disorders play an important role in IPF pathogenesis. Here, we show that …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder of unknown origin,
which ultimately leads to death. Several growth factors such as IGFs (insulin-like-growth …

Background Sex differences in idiopathic pulmonary fibrosis (IPF) suggest a protective role
for estrogen (E2); however, mechanistic studies in animal models have produced mixed …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor
prognosis. Inflammatory cytokines play a significant role in IPF pathology. However, the …

Background Interstitial pneumonia in connective tissue diseases (CTD-IP) featuring
inflammation and fibrosis is a leading cause of death in CTD-IP patients. The related …

Background Pathologic fibrosis is characterized by dysregulation of gene expression with
excessive extracellular matrix production. The genetic basis for solid organ fibrosis is well …